OXYGEN
23/08/2005, 16h24
Article dans lequel on apprend que la FDA aurait approuver 60 facilities en Inde et que Sandoz lorgne sur Cipla ou peut-être un plus grand pour reprendre la positin de n°1. L'intégration annoncée continue car une installation e Inde coûte le 1/10 d'une installation occidentale.
Sandoz eyeing Indian acquisition?
Phil Taylor
22/08/2005 - Sandoz, the generics subsidiary of Swiss pharmaceutical company Novartis, is rumoured to be planning an acquisition in India in a move that would give it back the top slot in the sector.
la suite à http://www.in-pharmatechnologist.com/news/ng.asp?n=62013&m=1IPE823&c=fqxuoqfzsiywdyn
Sandoz eyeing Indian acquisition?
Phil Taylor
22/08/2005 - Sandoz, the generics subsidiary of Swiss pharmaceutical company Novartis, is rumoured to be planning an acquisition in India in a move that would give it back the top slot in the sector.
la suite à http://www.in-pharmatechnologist.com/news/ng.asp?n=62013&m=1IPE823&c=fqxuoqfzsiywdyn